U.S. stock market update: Hims & Hers Health up 3.49%
I'm LongbridgeAI, I can summarize articles.Hims & Hers Health rose 3.49%; Basel Medical rose 70.87%, with a transaction volume of USD 218 million; CVS Health fell 0.83%, with a transaction volume of USD 178 million and a market value of USD 84 billion; Cigna fell 0.98%, with a transaction volume of USD 123 million
U.S. Stock Market Midday Update
Hims & Hers Health rose 3.49%. Based on recent important news:
-
On July 9, Hims & Hers Health announced plans to enter the Canadian market next year, with the stock price rising over 6% at one point. The company plans to offer low-cost treatment options through its digital platform.
-
On July 9, Hims & Hers Health's CFO Oluyemi Okupe sold company stock totaling $540,498.
-
On July 8, Hims & Hers Health faced multiple class-action lawsuits involving potential violations of securities laws.
Stocks with High Trading Volume in the Industry
Basel Medical rose 70.87%, with a trading volume of $218 million. Based on recent important news:
-
On June 12, executives from a Chinese biopharmaceutical company revealed at the Goldman Sachs Global Healthcare Conference that a significant external licensing deal would soon be finalized, driving the company's stock price up nearly 18%.
-
On June 26, Yaojie Ankang-B surged nearly 5% in the closing hours, reaching HKD 26.2, doubling from its IPO price, with a trading volume of HKD 29.2565 million.
-
On July 2, Minglida had a block trade of 6.651 million shares, with a trading volume of CNY 96.9051 million, accounting for 61.59% of the total trading volume that day, at a discount of 20.34%.
CVS Health fell 0.83%, with increased trading volume. Based on recent important news:
-
On July 9, a federal judge ruled that CVS Health's Omnicare division must pay nearly $949 million in fines for allegedly submitting false drug claims between 2010 and 2018, causing the stock price to drop.
-
On July 7, CVS announced a quarterly dividend of $0.665 per share, failing to boost market confidence.
-
On July 8, analysts rated CVS as a moderate buy but believed that five other stocks offered better investment value.
Cigna fell 0.98%, with increased trading volume. Based on recent important news:
-
On July 8, the Cigna Foundation announced a $3 million grant for mental health and housing stability for veterans, which did not have a direct impact on the stock price.
-
On July 7, the Hong Kong real estate market was active, which did not directly affect Cigna's stock price.
-
On July 7, the International Court of Justice is set to release opinions related to the Paris Agreement on July 23, which did not have a direct impact on Cigna.
Stocks with High Market Capitalization in the Industry
CVS Health fell 0.83%, with increased trading volume. Based on recent important news:
-
On July 9, a federal judge ordered CVS to pay nearly $949 million in fines related to false claims involving its Omnicare unit, causing the stock price to drop
-
On July 7th, CVS announced a quarterly dividend of $0.665 per share, which failed to boost the stock price.
-
On July 8th, analysts stated that CVS is not on the recommended buy list, affecting market confidence
